UNSPSC 51162101: Isoniazid/pyrazinamide/rifampin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM500. This VA Drug Class (AM500) classifies this compound as belonging to the group ANTITUBERCULARS.

UNSPSC 51162101 Isoniazid/pyrazinamide/rifampin is a Commodity code nominally tracking tuberculosis-treatment pharmaceuticals, but the recent state and local opportunities posted under it show minimal alignment with the code's specified scope. The two solicitations on record involve naloxone kits and drug deactivation systems (Seminole County, Florida) and comprehensive on-site pharmacy services including formulary management (Hall County, Georgia)—neither of which involves isoniazid combination therapy or tuberculosis treatment. The issuing bodies are county governments (a Florida county health procurement and a Georgia county employee health benefits function), but the work being bought does not match the code's nominal focus on a specific tuberculosis pharmaceutical combination.

No recent state and local procurement activity directly purchasing isoniazid/pyrazinamide/rifampin appears in the available record. The code shows little relevant recent activity; the two opportunities tagged to it represent a mismatch between the UNSPSC classification and the actual services or products being solicited. Firms monitoring this code for tuberculosis-treatment pharmaceutical procurement should verify whether state and local health departments, correctional agencies, or public health clinics have begun tagging TB-drug procurement under this or alternate codes, or may find their pursuit efforts more productively directed toward broader pharmaceutical-supply or public-health-clinic-services codes where actual tuberculosis-related activity is being posted.